These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis. Durham SR, Yang WH, Pedersen MR, Johansen N, Rak S. J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937 [Abstract] [Full Text] [Related]
5. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study. Bufe A, Ziegler-Kirbach E, Stoeckmann E, Heidemann P, Gehlhar K, Holland-Letz T, Braun W. Allergy; 2004 May; 59(5):498-504. PubMed ID: 15080830 [Abstract] [Full Text] [Related]
7. Double-blind, placebo-controlled evaluation of grass pollen specific immunotherapy with oral drops administered sublingually or supralingually. Panzner P, Petrás M, Sýkora T, Lesná I. Respir Med; 2008 Sep; 102(9):1296-304. PubMed ID: 18585908 [Abstract] [Full Text] [Related]
8. [Sublingual specific immunotherapy for rhinoconjunctivitis caused by grass pollens]. Sabbah A, Lesellin J, Hassoun S, Sicard H, André C. Allerg Immunol (Paris); 1993 Jun; 25(6):241-7. PubMed ID: 8357473 [Abstract] [Full Text] [Related]
9. Efficacy of sublingual coseasonal immunotherapy with a monomeric allergoid in Cupressaceae pollen allergy--preliminary data. Ariano R, Panzani RC, Mistrello G. Eur Ann Allergy Clin Immunol; 2005 Mar; 37(3):103-8. PubMed ID: 15918297 [Abstract] [Full Text] [Related]
10. Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis. Reich K, Gessner C, Kroker A, Schwab JA, Pohl W, Villesen H, Wüstenberg E, Emminger W. Clin Ther; 2011 Jul; 33(7):828-40. PubMed ID: 21741092 [Abstract] [Full Text] [Related]
11. Sustained 3-year efficacy of pre- and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen-induced rhinoconjunctivitis. Didier A, Worm M, Horak F, Sussman G, de Beaumont O, Le Gall M, Melac M, Malling HJ. J Allergy Clin Immunol; 2011 Sep; 128(3):559-66. PubMed ID: 21802126 [Abstract] [Full Text] [Related]
17. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis. Keskin O, Tuncer A, Adalioglu G, Sekerel BE, Saçkesen C, Kalayci O. Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684 [Abstract] [Full Text] [Related]
18. Safety and efficacy of sublingual rush immunotherapy with grass allergen extracts. A double blind study. Feliziani V, Lattuada G, Parmiani S, Dall'Aglio PP. Allergol Immunopathol (Madr); 1995 Sep; 23(5):224-30. PubMed ID: 8526180 [Abstract] [Full Text] [Related]
20. Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children. Valovirta E, Jacobsen L, Ljørring C, Koivikko A, Savolainen J. Allergy; 2006 Oct; 61(10):1177-83. PubMed ID: 16942565 [Abstract] [Full Text] [Related] Page: [Next] [New Search]